METHODE DE DIAGNOSTIC ET DE TRAITEMENT DU CANCER AU MOYEN D'ANTICORPS SE LIANT A UN INACTIVATEUR C1, A UNE PROTEINE REACTIVE C ET/OU A UN COMPOSANT C4 DU COMPLEMENT
The present invention relates among other things to a novel method of diagnosing cancer by applying antibodies that bind to human C1 inactivator, antibodies that bind to human C Reactive Protein and/or antibodies that bind to human Complement Component C4. Also the present invention relates to a pharmaceutical composition comprising one or more antibodies that bind to C inactivator, antibodies that bind to human C Reactive Protein and/or antibodies that bind to human Complement Component C4for use in the treatment of cancer, inhibiting growth of cancer and/or inhibiting proliferation of cancer.